<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>NACP - National AIDS Control Programme</title>
  <style>
    body {
      background-color: #000;
      font-family: 'Segoe UI', sans-serif;
      color: #f5f5dc;
      margin: 0;
      padding: 0;
    }

    header {
      background-color: #25ae8d;
      color: black;
      padding: 30px 20px;
      text-align: center;
    }

    header h1 {
      font-size: 36px;
      margin-bottom: 10px;
    }

    section {
      padding: 30px 20px;
      border-bottom: 1px solid rgba(255, 255, 255, 0.1);
      max-width: 1000px;
      margin: auto;
    }

    section h2 {
      color: #25ae8d;
      margin-bottom: 15px;
    }

    section h3 {
      color: #88ffe1;
      margin-top: 20px;
    }

    ul {
      padding-left: 20px;
      line-height: 1.7;
    }

    table {
      width: 100%;
      border-collapse: collapse;
      margin-top: 15px;
      background-color: #1a1a1a;
    }

    th, td {
      border: 1px solid #25ae8d;
      padding: 10px;
      text-align: left;
    }

    th {
      background-color: #25ae8d;
      color: black;
    }

    a {
      color: #25ae8d;
      text-decoration: none;
    }

    a:hover {
      text-decoration: underline;
    }

    footer {
      text-align: center;
      padding: 20px;
      background-color: #111;
      font-size: 14px;
      color: #999;
    }
  </style>
</head>
<body>

  <header>
    <h1>National AIDS Control Programme (NACP)</h1>
    <p>Combating HIV/AIDS Through Awareness, Treatment & Prevention</p>
  </header>

  <section>
    <h2>Target Group</h2>
    <ul>
      <li>High-risk groups: Female sex workers (FSWs), Men who have sex with men (MSM), Injecting drug users (IDUs), Migrants, Truckers</li>
      <li>People living with HIV/AIDS (PLHIV)</li>
      <li>Pregnant women and newborns (for prevention of transmission)</li>
      <li>General population (for awareness & education)</li>
    </ul>
  </section>

  <section>
    <h2>Eligibility Criteria</h2>
    <ul>
      <li>No income, age, gender or caste restriction</li>
      <li>All services are provided freely through public health systems</li>
      <li>Focus is given to high-risk and vulnerable populations</li>
    </ul>
  </section>

  <section>
    <h2>Introduction to the Programme</h2>
    <p>The National AIDS Control Programme (NACP) was launched in 1992 to tackle the growing HIV/AIDS epidemic in India. It is implemented by the National AIDS Control Organization (NACO) and has evolved over multiple phases focusing on prevention, treatment, care, and strengthening of health systems.</p>
  </section>

  <section>
    <h2>What It Contains (Key Interventions & Benefits)</h2>
    <ul>
      <li>Targeted Interventions for high-risk groups</li>
      <li>Free Antiretroviral Therapy (ART) at government centres</li>
      <li>Prevention of Parent-To-Child Transmission services</li>
      <li>Free HIV testing & counseling via ICTCs</li>
      <li>Safe blood supply under National Blood Policy</li>
      <li>HIV education for adolescents (NAEP)</li>
      <li>Community involvement via GIPA strategy</li>
      <li>Mainstreaming HIV response across ministries & civil society</li>
    </ul>
  </section>

  <section>
    <h2>Funding & Implementing Agencies</h2>
    <ul>
      <li><strong>Funded by:</strong> Government of India, Global Fund, World Bank & other international partners</li>
      <li><strong>Implemented by:</strong> NACO, State AIDS Control Societies (SACS), District Units (DAPCUs)</li>
      <li><strong>Support Structures:</strong> TSUs, STRCs, SIMS (for technical help, training, and monitoring)</li>
    </ul>
  </section>

  <section>
    <h2>Application Process</h2>
    <ul>
      <li>Direct walk-in access at ART Centres, ICTCs, and testing facilities</li>
      <li>No formal application or documentation needed for most services</li>
      <li>Outreach programs actively connect high-risk individuals to care</li>
    </ul>
  </section>

  <section>
    <h2>Timeline & Phases</h2>
    <table>
      <tr>
        <th>Phase</th>
        <th>Year</th>
        <th>Key Focus</th>
      </tr>
      <tr>
        <td>NACP-I</td>
        <td>1992–1999</td>
        <td>Awareness, surveillance, safe blood, targeted interventions</td>
      </tr>
      <tr>
        <td>NACP-II</td>
        <td>1999–2006</td>
        <td>Prevention-focused, ART rollout, blood policy, system building</td>
      </tr>
      <tr>
        <td>NACP-III</td>
        <td>2007–2012</td>
        <td>Goal: Halting and reversing the epidemic</td>
      </tr>
      <tr>
        <td>NACP-IV</td>
        <td>Post-2012</td>
        <td>Sustainability, community ownership, convergence with health systems</td>
      </tr>
    </table>
  </section>

  <section>
    <h2>Pros & Limitations</h2>
    <h3>Strengths:</h3>
    <ul>
      <li>Free access to testing and treatment for all</li>
      <li>Community-based, decentralized approach</li>
      <li>Global recognition for model implementation</li>
    </ul>
    <h3>Challenges:</h3>
    <ul>
      <li>Stigma and discrimination persist in some regions</li>
      <li>Logistics and ART stock-out issues in remote areas</li>
      <li>Need for sustained funding and outreach</li>
    </ul>
  </section>

  <section>
    <h2>Real-World Impact</h2>
    <p>India has successfully reduced new HIV infections by over 50% since the peak in the early 2000s. The number of people receiving ART has steadily grown, improving life expectancy and quality of life. Despite achievements, gaps remain in reaching marginalized groups and improving ART adherence.</p>
  </section>

  <section>
    <h2>Vision Forward</h2>
    <p>The NACP aligns with the Sustainable Development Goal (SDG) target of ending AIDS as a public health threat by 2030. The programme continues to focus on prevention, education, and treatment access with greater community participation.</p>
  </section>

  <footer>
    <p>For more info, visit the <a href="http://naco.gov.in" target="_blank">NACO Official Website</a>.</p>
    <p>&copy; 2025 MEDTrust. Empowering health through knowledge.</p>
  </footer>

</body>
</html>
